Already 4,256 people have seen this company's branding and they are being followed by 44 Storybook user.In average the company has been rated 4.8 points ja kommenteeritud 2 korda.

's activity report 2022

Allium UPI OÜ's field of activity is pharmacy cosmetics, dietary supplements, vitamins and hospital supplies, wholesale of medical technology. Its customers are practically all pharmacies, healthcare institutions and nursing homes across the country. In addition, Allium UPI OÜ provides marketing services to pharmacies carrying the Apotheka brand and to manufacturers or representatives of pharmaceutical and other pharmacy goods.

During the reporting period, Allium UPI OÜ actively participated in public procurements and price inquiries. The company will do the same in 2023. For the next year, the company forecasts good growth in the market for hospital supplies, medical technology, and dietary supplements, vitamins. The proportion of price inquiries in the field of medical technology and hospital supplies is increasing in addition to public procurements, which is due to customers' desire to purchase goods as cheaply as possible, even if the cost of the items to be purchased does not reach the limit for organizing a public procurement.

In the management's opinion, despite the changed economic environment, the company's credit risk has not significantly changed compared to the past. The company's liquidity risk is also low in the management's opinion, and it is able to fulfill its obligations to creditors. Since Allium UPI OÜ's business is essentially entirely in euros and the company operates mainly in the local market, the currency risk in the conventional sense is marginal. As a result, in the management's opinion, there is no need to use separate instruments to hedge currency risks. As of 30.04.2023, the company has no interest-bearing obligations, so possible changes in interest rates will not affect the company's financial results.

A stabilized and growing market is expected to attract new, heavily marketing-investing manufacturers of dietary supplements, vitamins and pharmacy cosmetics here.

Allium UPI OÜ owns 100% subsidiaries in Latvia and Lithuania.

In conclusion, the general development of the operating environment is cautiously positive. The Ukraine-Russia war and rapid inflation have caused a deterioration in the economic environment, which in turn may affect the company's financial results in the future. The current financial year report has been prepared in such a way that the possible impact of the economic environment has been taken into account in both the completed financial year report and the possible impact on the cash flows and financial position of the following financial years.

GENERAL FINANCIAL RESULTS

Company's financial indicators and ratios (in euros) 01.05.2022- 01.05.2021- 30.04.2023 30.04.2022

Sales revenue 68 255 998 64 631 426

Net profit 2 066 906 1 749 102

Total assets 35 094 201 28 042 211

Net profit margin, % 3.0% 2.7% = Net profit / Sales revenue*100

Asset productivity, % 6.5% 6.1% = Net profit / Assets (average for the year)*100

General liquidity ratio 3.5 5.6 = Current assets / Short-term liabilities

Debtor collection period = 365 * Claims against buyers (average for the year) / 9 9 Sales revenue period

Creditor payment period = 365 * Debts to suppliers (average for the year) / Sold 48 37 period production cost

Equity ratio, % 72% 83% = Equity/ Total assets*100